Unihealth Hospitals Limited — Investor Meet, 15-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. Financial Performance: UniHealth Consultancy Limited delivered a robust financial performance for H1 FY25, achieving consolidated revenues of ₹25.26 Cr, up 10.55% year-over-year. EBITDA reached ₹9.41 Cr, with a margin increase to 37.25%, a rise of 294 basis points. The net profit climbed by 23.19% to ₹5.23 Cr, yielding a net profit margin of 20.69%. The hospital and medical centers segment dominated revenue contribution at ₹20.40 Cr (81%), with consultancy services at ₹1.62 Cr (6%) and exports at ₹1.81 Cr (7%).

2. Future Outlook and Growth Drivers: Management expressed optimism for continued growth, focusing on expanding healthcare access in India and Africa. Plans include developing over 1,000 tertiary care beds and more than 25 medical and diagnostic centers. This expansion aligns with increasing demand for quality healthcare services, particularly in specialized areas like ophthalmology and cardiac care in Uganda and Nigeria.

3. Order Book and Operational Updates: Operational updates reveal advanced discussions for new facilities aimed to be commissioned by the end of the financial year, adding 100 beds in both India and Africa. The company plans strategic expansions while maintaining operational efficiency in existing locations.

4. Analyst Q&A Insights (Detailed):

- Revenue and Profitability: Analysts inquired about factors driving the increased margins, to which management attributed operational efficiencies and fixed costs remaining stable as revenues grow.

- Market Position and Competitive Landscape: Management acknowledged the potential margin pressure from new expansions, while maintaining confidence in future profitability.

- Operational Challenges or Risks: Questions on receivables turnover highlighted prolonged payment cycles with government clients, expected to improve as new facilities are commissioned.

- Capex and Capital Allocation: Management indicated that part of the IPO proceeds will fund capacity expansion, with further financing possibly sourced through bank debt.

- Strategic Priorities and Long-Term Vision: The company plans focused geographical expansion into Kenya and Ethiopia while seeking to diversify revenue streams to reduce dependency on Uganda.

5. Market or Regulatory Updates: No major regulatory changes were noted, although management discussed initiatives to enhance community access and healthcare quality in underserved regions.

6. Strategic Focus Areas: The company emphasizes operational efficiency, geographic diversification, and a commitment to addressing health care needs in developing markets, indicated by ongoing investments in local facilities.

7. Investor Insight: With strong financial health, a robust growth outlook, and a clear strategic direction, UniHealth presents an attractive opportunity. The expansion strategy, combined with management's commitment to operational excellence, aligns with a 'buy' position for retail investors.